EMEA (Europe, Middle East and Africa) RNA-based Biopharmaceuticals Market Report 2017

August 2017 | 113 pages | ID: E653795F006EN
QYResearch

Abstracts

In this report, the EMEA RNA-based Biopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of RNA-based Biopharmaceuticals for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA RNA-based Biopharmaceuticals market competition by top manufacturers/players, with RNA-based Biopharmaceuticals sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Roche
• Sanofi-Aventis
• Abbott Laboratories
• Arrowhead Pharmaceuticals
• Benitec Biopharma
• Calimmune Inc
• Dicerna
• Gradalis
• Quark
• RXi
• Senesco
• Silence Therapeutics
• Silenseed
• Tekmira
• Alnylam Pharmaceuticals

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Therapeutics
• Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of RNA-based Biopharmaceuticals for each application, including

• Cancer
• Diabetes
• Tuberculosis
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) RNA-based Biopharmaceuticals Market Report 2017

1 RNA-BASED BIOPHARMACEUTICALS OVERVIEW

1.1 Product Overview and Scope of RNA-based Biopharmaceuticals
1.2 Classification of RNA-based Biopharmaceuticals
  1.2.1 EMEA RNA-based Biopharmaceuticals Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA RNA-based Biopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Therapeutics
  1.2.4 Vaccines
1.3 EMEA RNA-based Biopharmaceuticals Market by Application/End Users
  1.3.1 EMEA RNA-based Biopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Cancer
  1.3.3 Diabetes
  1.3.4 Tuberculosis
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 EMEA RNA-based Biopharmaceuticals Market by Region
  1.4.1 EMEA RNA-based Biopharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of RNA-based Biopharmaceuticals (2012-2022)
  1.5.1 EMEA RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2022)
  1.5.2 EMEA RNA-based Biopharmaceuticals Revenue and Growth Rate (2012-2022)

2 EMEA RNA-BASED BIOPHARMACEUTICALS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA RNA-based Biopharmaceuticals Market Competition by Players/Manufacturers
  2.1.1 EMEA RNA-based Biopharmaceuticals Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA RNA-based Biopharmaceuticals Revenue and Share by Players (2012-2017)
  2.1.3 EMEA RNA-based Biopharmaceuticals Sale Price by Players (2012-2017)
2.2 EMEA RNA-based Biopharmaceuticals (Volume and Value) by Type/Product Category
  2.2.1 EMEA RNA-based Biopharmaceuticals Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA RNA-based Biopharmaceuticals Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA RNA-based Biopharmaceuticals Sale Price by Type (2012-2017)
2.3 EMEA RNA-based Biopharmaceuticals (Volume) by Application
2.4 EMEA RNA-based Biopharmaceuticals (Volume and Value) by Region
  2.4.1 EMEA RNA-based Biopharmaceuticals Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA RNA-based Biopharmaceuticals Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA RNA-based Biopharmaceuticals Sales Price by Region (2012-2017)

3 EUROPE RNA-BASED BIOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe RNA-based Biopharmaceuticals Sales and Value (2012-2017)
  3.1.1 Europe RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe RNA-based Biopharmaceuticals Revenue and Growth Rate (2012-2017)
3.2 Europe RNA-based Biopharmaceuticals Sales and Market Share by Type
3.3 Europe RNA-based Biopharmaceuticals Sales and Market Share by Application
3.4 Europe RNA-based Biopharmaceuticals Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe RNA-based Biopharmaceuticals Sales Volume by Countries (2012-2017)
  3.4.2 Europe RNA-based Biopharmaceuticals Revenue by Countries (2012-2017)
  3.4.3 Germany RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.4 France RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.5 UK RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.6 Russia RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.7 Italy RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.8 Benelux RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)

4 MIDDLE EAST RNA-BASED BIOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East RNA-based Biopharmaceuticals Sales and Value (2012-2017)
  4.1.1 Middle East RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East RNA-based Biopharmaceuticals Revenue and Growth Rate (2012-2017)
4.2 Middle East RNA-based Biopharmaceuticals Sales and Market Share by Type
4.3 Middle East RNA-based Biopharmaceuticals Sales and Market Share by Application
4.4 Middle East RNA-based Biopharmaceuticals Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East RNA-based Biopharmaceuticals Sales Volume by Countries (2012-2017)
  4.4.2 Middle East RNA-based Biopharmaceuticals Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  4.4.4 Israel RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  4.4.5 UAE RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  4.4.6 Iran RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)

5 AFRICA RNA-BASED BIOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa RNA-based Biopharmaceuticals Sales and Value (2012-2017)
  5.1.1 Africa RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa RNA-based Biopharmaceuticals Revenue and Growth Rate (2012-2017)
5.2 Africa RNA-based Biopharmaceuticals Sales and Market Share by Type
5.3 Africa RNA-based Biopharmaceuticals Sales and Market Share by Application
5.4 Africa RNA-based Biopharmaceuticals Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa RNA-based Biopharmaceuticals Sales Volume by Countries (2012-2017)
  5.4.2 Africa RNA-based Biopharmaceuticals Revenue by Countries (2012-2017)
  5.4.3 South Africa RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  5.4.5 Egypt RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)
  5.4.6 Algeria RNA-based Biopharmaceuticals Sales and Growth Rate (2012-2017)

6 EMEA RNA-BASED BIOPHARMACEUTICALS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi-Aventis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Arrowhead Pharmaceuticals
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Benitec Biopharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Calimmune Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Dicerna
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Gradalis
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Quark
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 RNA-based Biopharmaceuticals Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 RXi
6.12 Senesco
6.13 Silence Therapeutics
6.14 Silenseed
6.15 Tekmira
6.16 Alnylam Pharmaceuticals

7 RNA-BASED BIOPHARMACEUTICALS MANUFACTURING COST ANALYSIS

7.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 RNA-based Biopharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of RNA-based Biopharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA RNA-BASED BIOPHARMACEUTICALS MARKET FORECAST (2017-2022)

11.1 EMEA RNA-based Biopharmaceuticals Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA RNA-based Biopharmaceuticals Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA RNA-based Biopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA RNA-based Biopharmaceuticals Price and Trend Forecast (2017-2022)
11.2 EMEA RNA-based Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe RNA-based Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt RNA-based Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa RNA-based Biopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA RNA-based Biopharmaceuticals Sales Forecast by Type (2017-2022)
11.7 EMEA RNA-based Biopharmaceuticals Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of RNA-based Biopharmaceuticals
Figure EMEA RNA-based Biopharmaceuticals Sales Volume (K Units) by Type (2012-2022)
Figure EMEA RNA-based Biopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Therapeutics Product Picture
Figure Vaccines Product Picture
Figure EMEA RNA-based Biopharmaceuticals Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of RNA-based Biopharmaceuticals by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA RNA-based Biopharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure Europe RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe RNA-based Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Middle East RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East RNA-based Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Africa RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa RNA-based Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure EMEA RNA-based Biopharmaceuticals Sales Volume and Growth Rate (2012-2022)
Figure EMEA RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA RNA-based Biopharmaceuticals Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Sales Share by Players (2012-2017)
Figure 2016 RNA-based Biopharmaceuticals Sales Share by Players
Figure 2017 RNA-based Biopharmaceuticals Sales Share by Players
Figure EMEA RNA-based Biopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Revenue (Million USD) by Players (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Revenue Share by Players (2012-2017)
Table 2016 EMEA RNA-based Biopharmaceuticals Revenue Share by Players
Table 2017 EMEA RNA-based Biopharmaceuticals Revenue Share by Players
Table EMEA RNA-based Biopharmaceuticals Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Sales Share by Type (2012-2017)
Figure Sales Market Share of RNA-based Biopharmaceuticals by Type (2012-2017)
Figure EMEA RNA-based Biopharmaceuticals Sales Market Share by Type (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNA-based Biopharmaceuticals by Type in 2016
Table EMEA RNA-based Biopharmaceuticals Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Sales Share by Application (2012-2017)
Figure Sales Market Share of RNA-based Biopharmaceuticals by Application (2012-2017)
Figure EMEA RNA-based Biopharmaceuticals Sales Market Share by Application in 2016
Table EMEA RNA-based Biopharmaceuticals Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Sales Share by Region (2012-2017)
Figure Sales Market Share of RNA-based Biopharmaceuticals by Region (2012-2017)
Figure EMEA RNA-based Biopharmaceuticals Sales Market Share in 2016
Table EMEA RNA-based Biopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA RNA-based Biopharmaceuticals Revenue Share by Region (2012-2017)
Figure Revenue Market Share of RNA-based Biopharmaceuticals by Region (2012-2017)
Figure EMEA RNA-based Biopharmaceuticals Revenue Market Share Regions in 2016
Table EMEA RNA-based Biopharmaceuticals Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Europe RNA-based Biopharmaceuticals Revenue and Growth Rate (2012-2017)
Table Europe RNA-based Biopharmaceuticals Sales (K Units) by Type (2012-2017)
Table Europe RNA-based Biopharmaceuticals Market Share by Type (2012-2017)
Figure Europe RNA-based Biopharmaceuticals Market Share by Type in 2016
Table Europe RNA-based Biopharmaceuticals Sales (K Units) by Application (2012-2017)
Table Europe RNA-based Biopharmaceuticals Market Share by Application (2012-2017)
Figure Europe RNA-based Biopharmaceuticals Market Share by Application in 2016
Table Europe RNA-based Biopharmaceuticals Sales (K Units) by Countries (2012-2017)
Table Europe RNA-based Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe RNA-based Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe RNA-based Biopharmaceuticals Sales Market Share by Countries in 2016
Table Europe RNA-based Biopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Europe RNA-based Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe RNA-based Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe RNA-based Biopharmaceuticals Revenue Market Share by Countries in 2016
Figure Germany RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure France RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure UK RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Russia RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Italy RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East RNA-based Biopharmaceuticals Sales (K Units) by Type (2012-2017)
Table Middle East RNA-based Biopharmaceuticals Market Share by Type (2012-2017)
Figure Middle East RNA-based Biopharmaceuticals Market Share by Type (2012-2017)
Table Middle East RNA-based Biopharmaceuticals Sales (K Units) by Applications (2012-2017)
Table Middle East RNA-based Biopharmaceuticals Market Share by Applications (2012-2017)
Figure Middle East RNA-based Biopharmaceuticals Sales Market Share by Application in 2016
Table Middle East RNA-based Biopharmaceuticals Sales Volume (K Units) by Countries (2012-2017)
Table Middle East RNA-based Biopharmaceuticals Sales Volume Market Share by Countries (2012-2017)
Figure Middle East RNA-based Biopharmaceuticals Sales Volume Market Share by Countries in 2016
Table Middle East RNA-based Biopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Middle East RNA-based Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East RNA-based Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East RNA-based Biopharmaceuticals Revenue Market Share by Countries in 2016
Figure Saudi Arabia RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Israel RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure UAE RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Iran RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Africa RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Africa RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa RNA-based Biopharmaceuticals Sales (K Units) by Type (2012-2017)
Table Africa RNA-based Biopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Type in 2016
Table Africa RNA-based Biopharmaceuticals Sales (K Units) by Application (2012-2017)
Table Africa RNA-based Biopharmaceuticals Sales Market Share by Application (2012-2017)
Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Application (2012-2017)
Table Africa RNA-based Biopharmaceuticals Sales Volume (K Units) by Countries (2012-2017)
Table Africa RNA-based Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa RNA-based Biopharmaceuticals Sales Market Share by Countries in 2016
Table Africa RNA-based Biopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Africa RNA-based Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa RNA-based Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa RNA-based Biopharmaceuticals Revenue Market Share by Countries in 2016
Figure South Africa RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer RNA-based Biopharmaceuticals Basic Information List
Table Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Pfizer RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Roche RNA-based Biopharmaceuticals Basic Information List
Table Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Roche RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Roche RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis RNA-based Biopharmaceuticals Basic Information List
Table Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi-Aventis RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories RNA-based Biopharmaceuticals Basic Information List
Table Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Basic Information List
Table Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Benitec Biopharma RNA-based Biopharmaceuticals Basic Information List
Table Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Benitec Biopharma RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Benitec Biopharma RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Calimmune Inc RNA-based Biopharmaceuticals Basic Information List
Table Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Calimmune Inc RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Calimmune Inc RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Dicerna RNA-based Biopharmaceuticals Basic Information List
Table Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Dicerna RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Dicerna RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Gradalis RNA-based Biopharmaceuticals Basic Information List
Table Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gradalis RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Gradalis RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Gradalis RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Quark RNA-based Biopharmaceuticals Basic Information List
Table Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Quark RNA-based Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Quark RNA-based Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table RXi RNA-based Biopharmaceuticals Basic Information List
Table Senesco RNA-based Biopharmaceuticals Basic Information List
Table Silence Therapeutics RNA-based Biopharmaceuticals Basic Information List
Table Silenseed RNA-based Biopharmaceuticals Basic Information List
Table Tekmira RNA-based Biopharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA-based Biopharmaceuticals
Figure Manufacturing Process Analysis of RNA-based Biopharmaceuticals
Figure RNA-based Biopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of RNA-based Biopharmaceuticals Major Manufacturers in 2016
Table Major Buyers of RNA-based Biopharmaceuticals
Table Distributors/Traders List
Figure EMEA RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA RNA-based Biopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA RNA-based Biopharmaceuticals Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA RNA-based Biopharmaceuticals Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA RNA-based Biopharmaceuticals Sales Market Share Forecast by Region (2017-2022)
Table EMEA RNA-based Biopharmaceuticals Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA RNA-based Biopharmaceuticals Revenue Market Share Forecast by Region (2017-2022)
Table Europe RNA-based Biopharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe RNA-based Biopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Europe RNA-based Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe RNA-based Biopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East RNA-based Biopharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East RNA-based Biopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Middle East RNA-based Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East RNA-based Biopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Africa RNA-based Biopharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa RNA-based Biopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Africa RNA-based Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa RNA-based Biopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA RNA-based Biopharmaceuticals Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA RNA-based Biopharmaceuticals Sales Market Share Forecast by Type (2017-2022)
Table EMEA RNA-based Biopharmaceuticals Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA RNA-based Biopharmaceuticals Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources